AORT
Artivion Inc

320
Mkt Cap
$2.16B
Volume
443,720.00
52W High
$48.04
52W Low
$21.97
PE Ratio
-187.93
AORT Fundamentals
Price
$45.48
Prev Close
$44.21
Open
$44.57
50D MA
$44.14
Beta
1.02
Avg. Volume
422,820.42
EPS (Annual)
-$0.32
P/B
4.91
Rev/Employee
$242,835.63
Loading...
Loading...
News
all
press releases
ISRG Gets FDA Clearance to Use da Vinci SP Robot for General Surgeries
Intuitive Surgical broadens its da Vinci SP system with FDA clearance for three new surgeries, expanding its role in minimally invasive care.
Zacks·13h ago
News Placeholder
More News
News Placeholder
PLSE Starts Research Work on nPulse Technology to Treat Thyroid Tumor
Pulse Biosciences partners with MD Anderson to study its nPulse technology for treating benign and malignant thyroid tumors upon receiving FDA approval for a first-in-human trial.
Zacks·1d ago
News Placeholder
Insider Selling: Artivion (NYSE:AORT) CAO Sells 4,572 Shares of Stock
Artivion, Inc. (NYSE:AORT - Get Free Report) CAO Amy Horton sold 4,572 shares of the company's stock in a transaction on Monday, December 8th. The stock was sold at an average price of $44.42, for a...
MarketBeat·2d ago
News Placeholder
Russell Investments Group Ltd. Sells 68,082 Shares of Artivion, Inc. $AORT
Russell Investments Group Ltd. cut its holdings in Artivion, Inc. (NYSE:AORT - Free Report) by 40.1% during the second quarter, according to its most recent disclosure with the Securities & Exchange...
MarketBeat·4d ago
News Placeholder
Insider Selling: Artivion (NYSE:AORT) SVP Sells 7,315 Shares of Stock
Artivion, Inc. (NYSE:AORT - Get Free Report) SVP Jean Holloway sold 7,315 shares of the stock in a transaction on Wednesday, December 3rd. The shares were sold at an average price of $45.30, for a...
MarketBeat·6d ago
News Placeholder
Artivion (NYSE:AORT) SVP Sells 7,315 Shares
Artivion, Inc. (NYSE:AORT - Get Free Report) SVP Jean Holloway sold 7,315 shares of Artivion stock in a transaction dated Wednesday, December 3rd. The shares were sold at an average price of $45.30...
MarketBeat·7d ago
News Placeholder
Insider Selling: Artivion (NYSE:AORT) CEO Sells 30,921 Shares of Stock
Artivion, Inc. (NYSE:AORT - Get Free Report) CEO James Mackin sold 30,921 shares of the stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of...
MarketBeat·7d ago
News Placeholder
James Mackin Sells 30,921 Shares of Artivion (NYSE:AORT) Stock
Artivion, Inc. (NYSE:AORT - Get Free Report) CEO James Mackin sold 30,921 shares of the firm's stock in a transaction dated Tuesday, December 2nd. The shares were sold at an average price of $45.56...
MarketBeat·8d ago
News Placeholder
51,125 Shares in Artivion, Inc. $AORT Acquired by XTX Topco Ltd
XTX Topco Ltd bought a new stake in Artivion, Inc. (NYSE:AORT - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The...
MarketBeat·12d ago
News Placeholder
Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year?
Here is how Artivion (AORT) and Pacific Biosciences of California (PACB) have performed compared to their sector so far this year.
Zacks·16d ago

Latest AORT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.